Black Diamond Wealth Management Inc. Gilead Sciences, Inc. Transaction History
Black Diamond Wealth Management Inc.
- $152 Million
- Q3 2025
A detailed history of Black Diamond Wealth Management Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Black Diamond Wealth Management Inc. holds 2,262 shares of GILD stock, worth $280,691. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,262
Previous 1,831
23.54%
Holding current value
$280,691
Previous $203,000
23.65%
% of portfolio
0.17%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,368Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...